Sarin Chan
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
-
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
Papers in
-
- Tuberculosis Research and Epidemiology 6
-
- Mycobacterium research and diagnosis 4
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Pneumonia and Respiratory Infections 2
- Co-authors
- D A Mitchison (3 shared papers)Sok Thim (3 shared papers)Jean‐François Delfraissy (3 shared papers)F.–X. Blanc (3 shared papers)Didier Laureillard (3 shared papers)Laurence Borand (4 shared papers)Olivier Marcy (4 shared papers)Anne E. Goldfeld (3 shared papers)
In The Last Decade
Sarin Chan
11 papers receiving 282 citations
Peers
Comparison fields: 5 of 50
- Infectious Diseases 213
- Epidemiology 202
- Surgery 141
- Molecular Medicine 7
- Microbiology 1
Countries citing papers authored by Sarin Chan
This map shows the geographic impact of Sarin Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarin Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarin Chan more than expected).
Fields of papers citing papers by Sarin Chan
This network shows the impact of papers produced by Sarin Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarin Chan. The network helps show where Sarin Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarin Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 57 | |
| 2 | 1992 | 50 | |
| 3 | 2014 | 38 | |
| 4 | Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. | 2002 | 37 |
| 5 | 1997 | 30 | |
| 6 | 2019 | 25 | |
| 7 | 2014 | 23 | |
| 8 | Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. | 1997 | 12 |
| 9 | 1994 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2011 | 1 |
About Sarin Chan
Sarin Chan is a scholar working on Infectious Diseases, Epidemiology, Surgery, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, having authored 11 papers that have together received 295 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Infectious Diseases and Tuberculosis (3 papers), Pneumonia and Respiratory Infections (2 papers), Pharmaceutical studies and practices (2 papers), Pharmacological Effects and Toxicity Studies (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Infectious Diseases (213 citations), Epidemiology (202 citations), Surgery (141 citations), Molecular Medicine (7 citations) and Microbiology (1 citation). Sarin Chan has collaborated with scholars based in Cambodia, France and China. Frequent co-authors include D A Mitchison, Sok Thim, Jean‐François Delfraissy, F.–X. Blanc, Didier Laureillard, Laurence Borand, Olivier Marcy, Anne E. Goldfeld, Yoann Madec and K M Kam. Their work appears in journals such as AIDS, Clinical Infectious Diseases, BMC Pulmonary Medicine, Otolaryngology and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.